Asthma drug delivery manufacturer InfaMed, a subsidiary of Australian Stock Exchange-listed Visiomed, has appointed a Singaporean distributor of its patented paediatric asthma device, the Funhaler.

Asthma drug delivery manufacturer InfaMed, a subsidiary of Australian Stock Exchange-listed Visiomed, has appointed a Singaporean distributor of its patented paediatric asthma device, the Funhaler.